A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Clinical trial NCT02417064 · COMPLETED
Trial details
- NCT number
- NCT02417064
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-10
- Primary completion
- 2018-02-20
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.